Product
Tumor-associated antigen-specific T cell (TAA-T)
1 clinical trial
1 indication
Indication
Solid TumorClinical trial
Phase I Research Study Utilizing Allogeneic Multi Tumor-Associated Antigen-Specific T Lymphocytes to Advance the Care of Patients With High-Risk Solid TumorsStatus: Recruiting, Estimated PCD: 2025-10-01